Sirolimus DEB in Coronary Bifurcation Lesions

NCT04896177 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
280
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.